Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials.

Duconge J, Cadilla CL, Seip RL, Rua?o G. Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials. P R Health Sci J. 2015 Sep; 34(3):175-7.

View in: PubMed

subject areas

Algorithms
Anticoagulants
Aryl Hydrocarbon Hydroxylases
Female
Genotype
Humans
Male
Warfarin

authors with profiles

Carmen Cadilla
Jorge Duconge

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support